Study of Duodenal-Jejunal Bypass(DJB) as a Potential Cure for Type 2 Diabetes Mellitus
NCT00562029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2015-05-21
Summary
Premise: Complete resolution of Type 2 Diabetes Mellitus with normalization of blood glucose and HbA1c in the abscence of medication support is possible with a surgical procedure named the "Duodenal-Jejunal Bypass (DJB)" a modification of an established duodenal switch procedure and is performed utilizing the laparoscopic approach.
Conditions
Interventions
- PROCEDURE
-
Duodenal-jejunal Bypass
Patient has undergone a duodenal bypass and bypass of 60cm of proximal jejunum
Sponsors & Collaborators
-
Maffucci L, Rangraj M
collaborator UNKNOWN -
Sound Shore Medical Center of Westchester
lead OTHER
Principal Investigators
-
Leonard Maffucci, MD · Sound Shore Medical Center of Westchester
-
Madhu S Rangraj, MD · Sound Shore Medical Center of Westchester
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity in Type 2 Diabetes
NCT01202526 ·Status: COMPLETED
-
Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study
NCT00566215 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Determinants of Diabetes Remission After Gastric Bypass Surgery
NCT02287285 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Digital Diabetes Prevention Program Study
NCT06137963 ·Status: WITHDRAWN ·Phase: NA
-
Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes
NCT04782999 ·Status: COMPLETED ·Phase: NA
-
Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes
NCT01157403 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669 ·Status: RECRUITING
-
Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy
NCT02175459 ·Status: RECRUITING
-
Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes
NCT03130244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass
NCT05057819 ·Status: COMPLETED ·Phase: PHASE4
-
Omentectomy for the Treatment of Diabetes Mellitus Type 2
NCT00270439 ·Status: COMPLETED ·Phase: PHASE1
-
DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery
NCT00641251 ·Status: COMPLETED ·Phase: NA
-
The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
NCT01579981 ·Status: COMPLETED ·Phase: NA
-
β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed
NCT02199470 ·Status: COMPLETED
-
Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
NCT02777073 ·Status: COMPLETED ·Phase: NA
-
The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes
NCT00810823 ·Status: COMPLETED
-
A Study of the GI Sleeve for the Treatment of Type 2 Diabetes
NCT02709577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
NCT03217175 ·Status: TERMINATED ·Phase: NA
-
Neuroendocrine Brake for Type 2 Diabetes Mellitus
NCT00450710 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
NCT03743025 ·Status: TERMINATED ·Phase: PHASE4
-
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
NCT03620773 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01843855 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
NCT03685773 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
NCT00947011 ·Status: TERMINATED ·Phase: PHASE2